---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-130486"
form_type: "8-K"
ticker: "SGMT"
cik: "0001400118"
company_name: "Sagimet Biosciences Inc."
filed_at: "2023-12-29T23:59:59+00:00"
generated_at: "2026-06-07T05:47:01.674935+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# CFO Anthony Rimac to resign Jan. 31, 2024; interim appointments from Stout

## Summary
- CFO Anthony Rimac resigns effective Jan. 31, 2024 for personal reasons; no disagreement with company or auditors.
- Stout's Gaeton Biscardi named Interim VP of Finance; Joe Oriti to serve as consultant and likely Interim Principal Financial Officer.
- Board intends to appoint Oriti as Interim PFO and will conduct a search for a permanent CFO.

## SEC filing metadata
- accession: 0001104659-23-130486
- form_type: 8-K
- ticker: SGMT
- cik: 0001400118
- company_name: Sagimet Biosciences Inc.
- filed_at: 2023-12-29T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1400118/000110465923130486/0001104659-23-130486-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1400118/000110465923130486/tm2333876d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-130486
- JSON: https://secwatch.observer/filing/0001104659-23-130486.json
- Plain text: https://secwatch.observer/filing/0001104659-23-130486.txt

## Key facts
- Executive change
  Anthony Rimac resigned as Chief Financial Officer at Sagimet Biosciences Inc..
  - Action: resigned
  - Role: Chief Financial Officer
  source text: Anthony Rimac provided notice of his intent to step down as the Chief Financial Officer of Sagimet Biosciences Inc. (the “ Company ”) effective January 31, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1400118/000110465923130486/0001104659-23-130486-index.htm
- Executive change
  Gaeton Biscardi was appointed as Interim VP of Finance at Sagimet Biosciences Inc..
  - Action: appointed
  - Role: Interim VP of Finance
  source text: Gaeton Biscardi, Managing Director of Stout, will be serving as the Company’s Interim VP of Finance during this transition period
  evidence_url: https://www.sec.gov/Archives/edgar/data/1400118/000110465923130486/0001104659-23-130486-index.htm
- Executive change
  Joe Oriti was appointed as Interim Principal Financial Officer at Sagimet Biosciences Inc..
  - Action: appointed
  - Role: Interim Principal Financial Officer
  source text: the Company intends to appoint Mr. Oriti as Interim Principal Financial Officer of the Company following Mr. Rimac’s departure
  evidence_url: https://www.sec.gov/Archives/edgar/data/1400118/000110465923130486/0001104659-23-130486-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.